The Russia-led Eurasian Economic Union is interested in expanding east and sign a free trade agreement with Hong Kong, according to Russia’s Deputy Prime Minister Arkady Dvorkovich.

“We recently concluded the free trade zone agreement between the Eurasian Economic Union and Vietnam and are currently negotiating with Israel. We are ready to discuss this issue with Hong Kong,”

said Dvorkovich, speaking at the Asia Financial Forum in Hong Kong.

The EEU is a trade bloc established in 2015 on the basis of the Customs Union of Russia, Kazakhstan and Belarus. It currently has five members: Russia, Armenia, Belarus, Kazakhstan, Kyrgyzstan, while Tajikistan is a prospective member.

Western sanctions have encouraged Russia to work more actively with Asian partners. In May last year, the EEU and Vietnam signed a free trade zone agreement. It became the first free trade zone between the trade bloc and a third party. According to the documents prepared for the signing ceremony, the free trade zone is going to save exporters from the EEU about $40-60 million in the first year of operation.

Source: Russia wants free trade zone with Hong Kong — RT Business

About the author

Leave a Reply

Sign Up for Our Newsletter

Get notified of our weekly selection of news

You May Also Like

SET Index Series Semi-annual Review

FTSE Russell has partnered with The Stock Exchange of Thailand (SET) to jointly create the FTSE SET Index Series for the Thai stock market representing various sizes of companies, sectors and themes.

Global merchandise trade exceeds pre-COVID-19 level

Global merchandise trade exceeds pre-COVID-19 level, but services recovery falls short. UNCTAD nowcasts show that trade in services has not yet reached its pre-pandemic level, while merchandise trade is projected to have surpassed it by 15%.

Vietnam to Increase Production of Russia’s COVID-19 Vaccine

An initial investment of around US$60-US$70 million will enable the technical implementation of the project to begin in early 2022 before full-fledged production starts in early 2023. The facility is expected to produce some 40 million doses of the two-component vaccine per year.